Literature DB >> 26183009

Stage 3 Medication-Related Osteonecrosis of the Posterior Maxilla: Surgical Treatment Using a Pedicled Buccal Fat Pad Flap: Case Reports.

Mattia Berrone1, Filippo Umberto Florindi2, Vincenzo Carbone3, Carola Aldiano2, Monica Pentenero4.   

Abstract

PURPOSE: Stage 3 medication-related osteonecrosis of the jaw (MRONJ) sometimes requires surgical treatment for resolution of the pathology and, in many cases, leads to oroantral communication in the posterior maxilla. The buccal fat pad flap is considered the best surgical choice for closure of large oroantral communications because it provides primary closure and guarantees adequate bone protection with sufficient blood supply for an effective bone healing process.
MATERIALS AND METHODS: Five consecutive patients affected by stage 3 posterior maxillary MRONJ were treated with surgical removal of the necrotic bone and primary closure of the oroantral communication using a buccal fat pad flap.
RESULTS: In each case, the size of the flap was always sufficient to perfectly close the defect without tension. There were no postoperative complications and the average postoperative hospital stay was 3 ± 1 days. The patients were seen at monthly follow-ups; after 12 ± 4 months of follow-up, no problems were noted in the treated area.
CONCLUSION: Despite the limited number of cases, the results of this study suggest that, for stage 3 posterior maxilla MRONJ, managing the site with a pedicled buccal fat pad flap and primary closure might guarantee adequate bone protection with sufficient blood supply for an effective bone healing process.
Copyright © 2015 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26183009     DOI: 10.1016/j.joms.2015.06.165

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  10 in total

1.  Surgical treatment of 61 consecutive patients with maxillary stage 3 medication-related osteonecrosis of the jaws using a pedicled buccal fat pad.

Authors:  Sanne Werner Moeller Andersen; Ditte Gertz Mogensen; Morten Schioedt; Thomas Kofod
Journal:  Oral Maxillofac Surg       Date:  2022-04-01

2.  Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.

Authors:  Mitsunobu Otsuru; Saki Hayashida; Kota Morishita; Maho Murata; Sakiko Soutome; Miho Sasaki; Yukinori Takagi; Misa Sumi; Masahiro Umeda
Journal:  Int J Environ Res Public Health       Date:  2022-06-17       Impact factor: 4.614

3.  The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols.

Authors:  Olga Di Fede; Federica Canepa; Vera Panzarella; Rodolfo Mauceri; Carmine Del Gaizo; Alberto Bedogni; Vittorio Fusco; Pietro Tozzo; Giuseppe Pizzo; Giuseppina Campisi; Antonio Galvano
Journal:  Int J Environ Res Public Health       Date:  2021-08-10       Impact factor: 3.390

4.  The Effectiveness of the Low-Level Laser, Antibiotic and Surgical Therapy in the Treatment of Medication-Related Osteonecrosis of the Jaws: A Case Report.

Authors:  Maria Del Pilar Rodríguez-Sánchez; Cristian Statkievicz; João Martins de Mello-Neto; Luan Felipe Toro; Ana Paula Farnezzi Bassi; Valdir Gouveia Garcia; Letícia Helena Theodoro; Edilson Ervolino
Journal:  J Lasers Med Sci       Date:  2020-01-18

5.  Monolateral sinonasal complications of dental disease or treatment: when does endoscopic endonasal surgery require an intraoral approach?

Authors:  G L Fadda; M Berrone; E Crosetti; G Succo
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-08       Impact factor: 2.124

Review 6.  Odontogenic Sinusitis: From Diagnosis to Treatment Possibilities-A Narrative Review of Recent Data.

Authors:  Cristian Martu; Maria-Alexandra Martu; George-Alexandru Maftei; Diana Antonela Diaconu-Popa; Luminita Radulescu
Journal:  Diagnostics (Basel)       Date:  2022-06-30

7.  Simultaneous defect reconstruction in stage 3 medication-related osteonecrosis of the maxilla and mandible using the buccal fat flap and submental island flap: Case report.

Authors:  Yoshinari Myoken; Takeshi Kawamoto; Yoshinori Fujita; Shigeaki Toratani
Journal:  J Dent Sci       Date:  2021-12-02       Impact factor: 3.719

Review 8.  Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw.

Authors:  Lina He; Xiangyu Sun; Zhijie Liu; Yanfen Qiu; Yumei Niu
Journal:  Int J Oral Sci       Date:  2020-10-21       Impact factor: 6.344

9.  Human amniotic membrane: an improvement in the treatment of Medication-related osteonecrosis of the jaw (MRONJ)? A case-control study.

Authors:  Mirko Ragazzo; Matteo Val; Giulia Montagner; Diletta Trojan; Stefano Fusetti; Luca Guarda Nardini
Journal:  Cell Tissue Bank       Date:  2021-04-15       Impact factor: 1.522

10.  Patients' quality of life improves after surgical intervention of stage III medication-related osteonecrosis of the jaw.

Authors:  Stefan Moll; Steffen Mueller; Johannes K Meier; Torsten E Reichert; Tobias Ettl; Christoph Klingelhöffer
Journal:  Oral Maxillofac Surg       Date:  2020-11-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.